EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: a bibliometric analysis of global research trends and research hotspots from 2006 to 2025

Qinsheng Bi, Liangyi Zhang, Jiaxin Zhang, Xin Wang, Changlin Zuo, Shijie Zhao, Zairong Wang, Zilin Zhao, Hejia Wan iD

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-026-05635-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Qinsheng Bi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Joint Institute of Management and Science University at Henan University of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou, 450046…. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Glucagon-Like Peptide-1 Receptor Agonists, Biomedical Research. Die Arbeit nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to systematically characterize the global research landscape, collaboration patterns, knowledge structure, and emerging hotspots of glucagon-like peptide-1 receptor agonists in neurodegenerative diseases using bibliometric methods. Publications related to glucagon-like peptide-1 receptor agonists and neurodegenerative diseases were retrieved from the Web of Science Core Collection from 2006 to 2025. Only English-language articles and reviews were included. Bibliometric analyses were performed using Bibliometrix, VOSviewer, and CiteSpace to evaluate annual publication trends, country and institutional contributions, author collaborations, journal distribution, citation structures, keyword co-occurrence, thematic evolution, and citation bursts. A Scopus-based sensitivity analysis was conducted to assess the robustness of the main bibliometric findings. A total of 1,202 publications were included, with annual output increasing from 2 in 2006 to 241 in 2025, particularly after 2020. China, the USA, and England were the leading contributors and major collaboration hubs. Shanxi Medical University, Lancaster University, and the National Institute on Aging were among the most productive institutions, while major journals included International Journal of Molecular Sciences, Neuropharmacology, European Journal of Pharmacology, Frontiers in Endocrinology, Frontiers in Pharmacology, and Journal of Alzheimer's Disease. Keyword and citation analyses indicated a thematic shift from exendin-4, Alzheimer's disease, Parkinson's disease, and neuroprotection toward semaglutide, neuroinflammation, cognitive impairment, clinical efficacy, evidence synthesis, and combination therapy. Research on glucagon-like peptide-1 receptor agonists in neurodegenerative diseases has expanded rapidly over the past two decades. Current bibliometric evidence suggests that this field has evolved from preclinical exploration toward broader translational and clinical research, with increasing attention to neuroinflammation, metabolic dysfunction, cognitive outcomes, and newer incretin-based therapies. However, the therapeutic implications of glucagon-like peptide-1 receptor agonists for neurodegenerative diseases remain to be further validated by high-quality mechanistic studies and well-designed clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesGlucagon-Like Peptide-1 Receptor AgonistsBiomedical ResearchHumansBibliometricsAnimalsSemaglutideGlucagon-Like Peptide-1 Receptor

Stichwörter der Autor:innen

Alzheimer’s diseaseBibliometric analysisGLP-1 receptor agonistsNeurodegenerative diseasesNeuroinflammationParkinson’s diseaseResearch hotspotsSemaglutide

Substanzen

Glucagon-Like Peptide-1 Receptor AgonistsSemaglutideGlucagon-Like Peptide-1 Receptor

Autor:innen und Institutionen

  • Joint Institute of Management and Science University at Henan University of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou, 450046, Henan, China.
  • Department of Gynecological Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China.
  • School of Nursing (Nursing School of Smart Healthcare Industry), Henan University of Chinese Medicine, Zhengzhou, 450046, Henan, China.
  • The Second Department of Pediatric, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 451200, Henan, China.
  • School of Nursing (Nursing School of Smart Healthcare Industry), Henan University of Chinese Medicine, Zhengzhou, 450046, Henan, China. zzl20210225@163.com.
  • School of Nursing (Nursing School of Smart Healthcare Industry), Henan University of Chinese Medicine, Zhengzhou, 450046, Henan, China. 2240536681@qq.com.

ORCID-Profile: Hejia Wan

Zitieren

APA

Bi, Q., Zhang, L., Zhang, J., Wang, X., Zuo, C., Zhao, S., Wang, Z., Zhao, Z., & Wan, H. (2026). Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: a bibliometric analysis of global research trends and research hotspots from 2006 to 2025. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05635-9

Vancouver

Bi Q, Zhang L, Zhang J, Wang X, Zuo C, Zhao S, et al. Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: a bibliometric analysis of global research trends and research hotspots from 2006 to 2025. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05635-9

BibTeX
@article{Bi2026,
  author = {Bi, Qinsheng and Zhang, Liangyi and Zhang, Jiaxin and Wang, Xin and Zuo, Changlin and Zhao, Shijie and Wang, Zairong and Zhao, Zilin and Wan, Hejia},
  title = {Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: a bibliometric analysis of global research trends and research hotspots from 2006 to 2025},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-026-05635-9}
}
Kostenlos starten →